Focus Taiwan App
Download

CECC planning partnership to develop COVID-19 antibody treatments

01/15/2021 07:07 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

The Central Epidemic Command Center (CECC) is planning to launch a public-private partnership to develop and produce antibody treatments against COVID-19, according to the National Health Research Institutes (NHRI).


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.43